WARFARIN ORION PHARMA

WARFARIN ORION PHARMA

Marketed by: Orion Corporation, Orion Pharma
Active ingredient: Warfarinum natricum
Other information: tablet - 3 mg

Available in: Finland
Language: English
Source: Fimea

WARFARIN ORION PHARMA

WARFARIN ORION PHARMA

Marketed by: Orion Corporation, Orion Pharma
Active ingredient: Warfarinum natricum
Other information: tablet - 5 mg

Available in: Finland
Language: English
Source: Fimea

WILATE

WILATE

Marketed by: Octapharma Ab
Active ingredient: Factor von Willebrand coagulationes humanus,Factor VIII coagulationis humanus
Other information: powder and solvent for solution for injection

Available in: Finland
Language: English
Source: Fimea

WILFACTIN

WILFACTIN

Marketed by: LFB Biomedicaments
Active ingredient: Factor von Willebrand coagulationes humanus
Other information: powder and solvent for solution for injection - 100 IU/ml

Available in: Finland
Language: English
Source: Fimea

WICARBA

WICARBA

Marketed by: Louis Widmer GmbH
Active ingredient: Ureum,Retinoli palmitas,Dexpanthenolum
Other information: cream

Available in: Finland
Language: English
Source: Fimea

WICARAN

WICARAN

Marketed by: Louis Widmer GmbH
Active ingredient: Tretinoinum,Ureum,Dexpanthenolum
Other information: cream

Available in: Finland
Language: English
Source: Fimea

WAXTAR

WAXTAR

Marketed by: Nycomed Pharma-Medica As
Active ingredient: Pyroleum lithanthracis
Other information: stick - 5 %

Available in: Finland
Language: English
Source: Fimea

WARTEC

WARTEC

Marketed by: Pfizer Health Ab
Active ingredient: Podophyllotoxinum
Other information: solution for paint - 5 mg/ml

Available in: Finland
Language: English
Source: Fimea

WARTEC

WARTEC

Marketed by: GlaxoSmithKline Oy
Active ingredient: Podophyllotoxinum
Other information: solution for paint - 5 mg/ml

Available in: Finland
Language: English
Source: Fimea

WARTEC

WARTEC

Marketed by: GlaxoSmithKline Oy
Active ingredient: Podophyllotoxinum
Other information: cream - 0.15 %

Available in: Finland
Language: English
Source: Fimea

WARTEC

WARTEC

Marketed by: Conpharm Ab
Active ingredient: Podophyllotoxinum
Other information: solution for paint - 5 mg/ml

Available in: Finland
Language: English
Source: Fimea

WICNELACT

WICNELACT

Marketed by: Louis Widmer GmbH
Active ingredient: Magnesii sulfas,Zinci sulfas,Acidum lacticum,Triclosanum,Acidum salicylicum
Other information: cutaneous solution

Available in: Finland
Language: English
Source: Fimea

WICNELACT DEXA

WICNELACT DEXA

Marketed by: WIDMER
Active ingredient: Hexachlorophenum,Acidum lacticum,Acidum salicylicum,Dexamethasonum,Magnesii sulfas,Zinci sulfas
Other information: liniment

Available in: Finland
Language: English
Source: Fimea

WICNE

WICNE

Marketed by: Louis Widmer GmbH
Active ingredient: Silica colloidalis anhydrica,Acidum salicylicum,Sulfur colloidale,Triclosanum
Other information: cream

Available in: Finland
Language: English
Source: Fimea

WICNECARB

WICNECARB

Marketed by: Louis Widmer GmbH
Active ingredient: Sulfur colloidale,Ureum,Triclosanum,Pyridoxini hydrochloridum
Other information: gel

Available in: Finland
Language: English
Source: Fimea

WICNE FORTE C.RESORCIN.

WICNE FORTE C.RESORCIN.

Marketed by: WIDMER
Active ingredient: Sulfur colloidale,Hexachlorophenum,Acidum silicicum,Resorcinum,Acidum salicylicum
Other information: cream

Available in: Finland
Language: English
Source: Fimea

WICNEVIT

WICNEVIT

Marketed by: Louis Widmer GmbH
Active ingredient: Triclosanum,Pyridoxini hydrochloridum,Dexpanthenolum,Ureum,Retinoli palmitas
Other information: cream

Available in: Finland
Language: English
Source: Fimea

WIBOCET

WIBOCET

Marketed by: WIDMER
Active ingredient: Cholini chloridum,Cetrimonii bromidum,Natrii thiosulfas pentahydricus
Other information: liniment

Available in: Finland
Language: English
Source: Fimea

WIBOMILD

WIBOMILD

Marketed by: WIDMER
Active ingredient: Triclosanum
Other information: shampoo

Available in: Finland
Language: English
Source: Fimea

WELLCOPRIM

WELLCOPRIM

Marketed by: The Wellcome Foundation Limited
Active ingredient: Trimethoprimum
Other information: tablet - 100 mg

Available in: Finland
Language: English
Source: Fimea

WINRHO SDF

WINRHO SDF

Marketed by: Cangene Europe Limited
Active ingredient: Immunoglobulinum humanum anti-D
Other information: powder and solvent for solution for injection/infusion - 600 IU

Available in: Finland
Language: English
Source: Fimea

WINRHO SDF

WINRHO SDF

Marketed by: Cangene Europe Limited
Active ingredient: Immunoglobulinum humanum anti-D
Other information: powder and solvent for solution for injection/infusion - 1500 IU

Available in: Finland
Language: English
Source: Fimea

WINRHO SDF

WINRHO SDF

Marketed by: Cangene Europe Limited
Active ingredient: Immunoglobulinum humanum anti-D
Other information: powder and solvent for solution for injection/infusion - 5000 IU

Available in: Finland
Language: English
Source: Fimea

WOLFUTAMIDE

WOLFUTAMIDE

Marketed by: Helm Pharmaceuticals GmbH
Active ingredient: Bicalutamidum
Other information: film-coated tablet - 150 mg

Available in: Finland
Language: English
Source: Fimea

WELLFERON

WELLFERON

Marketed by: The Wellcome Foundation Limited
Active ingredient: Interferonum alfa-2
Other information: injection - 3 milj.IU/ml

Available in: Finland
Language: English
Source: Fimea

WELLFERON

WELLFERON

Marketed by: The Wellcome Foundation Limited
Active ingredient: Interferonum humanum (lymphoplastoid.)
Other information: injection - 10 milj.IU/ml

Available in: Finland
Language: English
Source: Fimea

WELLFERON

WELLFERON

Marketed by: The Wellcome Foundation Limited
Active ingredient: Interferonum humanum (lymphoplastoid.)
Other information: injection - 5 milj.IU/ml

Available in: Finland
Language: English
Source: Fimea

WELLDEX VET

WELLDEX VET

Marketed by: PITMAN
Active ingredient: Ferri hydroxidum dextranum complex
Other information: injection - 100 mg Fe+++/ml

Available in: Finland
Language: English
Source: Fimea

WARBEX VET

WARBEX VET

Marketed by: Lederle Laboratories (divison Of American Cyanamid)
Active ingredient: Famphur
Other information: injection - 350 mg/ml

Available in: Finland
Language: English
Source: Fimea

WELPAN VET.

WELPAN VET.

Marketed by: Bayer HealthCare AG Animal Health Division
Active ingredient: Pyranteli embonas,Febantelum
Other information: oral suspension - 15 mg/ml + 5 mg/ml

Available in: Finland
Language: English
Source: Fimea